Our mission is to improve brain health of people with serious neurological diseases through the application of digital technologies. Established in 2004 and a public company since October 2013, we are a trusted partner to the global biopharma industry, providing technology-enabled speciality services. Our company values of Expertise, Innovation, Quality and Integrity underpin how we do this.
Our neuroscience expertise in image data management and specialist data analytics services are used to select patients for clinical trials, assess the safety and efficacy of drugs in development and in post marketing surveillance. Our neurological disease focus includes Alzheimer’s disease, Huntington’s disease, Multiple Sclerosis, Progressive Supranuclear Palsy and Parkinson’s disease.
Our competitive advantage is in our ability to improve the efficiency and value that our biopharma clients derive from collecting and analysing clinically meaningful, regulatory compliant data, to make better informed decisions. We are uniquely positioned to deliver these approaches by further innovating, customising and scaling our integrated digital platform.
Our people make all this happen. We have a passionate and dedicated team, bringing together the essential skills required to innovate and develop cutting-edge technologies to provide the support our clients need.
To speak to one of our experts and find out more